376 related articles for article (PubMed ID: 29157611)
21. EBV+ HHV-8+ Multicentric Castleman Disease With Plasmablastic Aggregates in an HIV+ Man: An Evolving Clinicopathologic Entity.
Shivane A; Pearce A; Khatib N; Smith MEF
Int J Surg Pathol; 2018 Jun; 26(4):338-341. PubMed ID: 29198143
[TBL] [Abstract][Full Text] [Related]
22. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M; Wong R; Wu D; Maillard I; Brandstadter J; Munshi N; Bowne W; Elenitoba-Johnson KS; Fössa A; Lechowicz MJ; Chandrakasan S; Pierson SK; Greenway A; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Chadburn A; Fajgenbaum DC
Blood Adv; 2020 Dec; 4(23):6039-6050. PubMed ID: 33284946
[TBL] [Abstract][Full Text] [Related]
23. Castleman Disease Pathogenesis.
Fajgenbaum DC; Shilling D
Hematol Oncol Clin North Am; 2018 Feb; 32(1):11-21. PubMed ID: 29157613
[TBL] [Abstract][Full Text] [Related]
24. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.
Dupin N; Diss TL; Kellam P; Tulliez M; Du MQ; Sicard D; Weiss RA; Isaacson PG; Boshoff C
Blood; 2000 Feb; 95(4):1406-12. PubMed ID: 10666218
[TBL] [Abstract][Full Text] [Related]
25. Use of a claims database to characterize and estimate the incidence rate for Castleman disease.
Munshi N; Mehra M; van de Velde H; Desai A; Potluri R; Vermeulen J
Leuk Lymphoma; 2015 May; 56(5):1252-60. PubMed ID: 25120049
[TBL] [Abstract][Full Text] [Related]
26. Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study.
Yu T; Cai QQ; Zhai QL; Li L; Fang X; Li J; Sun R; Yang H; Wang Z; Qian W; Xu-Monette ZY; Young KH; Yu L
Leuk Lymphoma; 2022 Dec; 63(13):3082-3091. PubMed ID: 36074798
[TBL] [Abstract][Full Text] [Related]
27. A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Zhang L; Dong YJ; Peng HL; Li H; Zhang MZ; Wang HH; Liu QH; Su LP; Zhong LY; Wu WJ; Huang L; Yan XJ; Fan L; Tang WJ; Li ZL; Bi LT; Li Y; Gao GX; Gao L; Liu TB; Wei YQ; Liu Y; Yu L; Zhou H; Sun CY; Qian WB; Zou DH; Zhang HL; Ding KY; Wang XB; Bai O; Huang WR; Chen B; Yang L; Song J; Gao D; Chen T; Luo J; Wang SY; Ma LM; Fajgenbaum DC; Li J;
Lancet Reg Health West Pac; 2023 May; 34():100720. PubMed ID: 37283978
[TBL] [Abstract][Full Text] [Related]
28. Historical and pathological overview of Castleman disease.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
[TBL] [Abstract][Full Text] [Related]
29. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
[TBL] [Abstract][Full Text] [Related]
30. Multicentric Castleman disease and the evolution of the concept.
Zhou T; Wang HW; Pittaluga S; Jaffe ES
Pathologica; 2021 Oct; 113(5):339-353. PubMed ID: 34837092
[TBL] [Abstract][Full Text] [Related]
31. A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.
Yu L; Shi M; Cai Q; Strati P; Hagemeister F; Zhai Q; Li L; Fang X; Li J; Sun R; Zhang S; Yang H; Wang Z; Qian W; Iwaki N; Sato Y; Zhang L; Li J; Oksenhendler E; Xu-Monette ZY; Young KH
Oncologist; 2020 Nov; 25(11):963-973. PubMed ID: 32852137
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of Castleman disease.
Soumerai JD; Sohani AR; Abramson JS
Cancer Control; 2014 Oct; 21(4):266-78. PubMed ID: 25310208
[TBL] [Abstract][Full Text] [Related]
33. ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease.
Van Nieuwenhove E; Humblet-Baron S; Van Eyck L; De Somer L; Dooley J; Tousseyn T; Hershfield M; Liston A; Wouters C
Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30139808
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus-associated multicentric Castleman disease refractory to antiretroviral therapy: clinical features, treatment and outcome.
Alzahrani M; Hull MC; Sherlock C; Griswold D; Leger CS; Leitch HA
Leuk Lymphoma; 2015 May; 56(5):1246-51. PubMed ID: 25093377
[TBL] [Abstract][Full Text] [Related]
35. Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease.
Siegel MO; Ghafouri S; Ajmera R; Simon GL
Int J Infect Dis; 2016 Jul; 48():49-51. PubMed ID: 27173076
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease.
Dong Y; Zhang L; Nong L; Wang L; Liang Z; Zhou D; Fajgenbaum DC; Ren H; Li J
Ann Hematol; 2018 Sep; 97(9):1641-1647. PubMed ID: 29732477
[TBL] [Abstract][Full Text] [Related]
37. Multicentric Castleman disease: Where are we now?
Wang HW; Pittaluga S; Jaffe ES
Semin Diagn Pathol; 2016 Sep; 33(5):294-306. PubMed ID: 27296355
[TBL] [Abstract][Full Text] [Related]
38. Clinical and histopathology characteristics of Castleman disease: a multicenter study of 51 Brazilian patients.
Leite JM; Barrese TZ; Sementilli L; de Freitas LLL; do Espirito Santo KS; Delamain MT; Baiocchi OCCG; Brasil SAB; Chiattone CS
Ann Hematol; 2023 May; 102(5):1121-1129. PubMed ID: 36763110
[TBL] [Abstract][Full Text] [Related]
39. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.
Fajgenbaum DC; van Rhee F; Nabel CS
Blood; 2014 May; 123(19):2924-33. PubMed ID: 24622327
[TBL] [Abstract][Full Text] [Related]
40. HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.
Sullivan RJ; Pantanowitz L; Casper C; Stebbing J; Dezube BJ
Clin Infect Dis; 2008 Nov; 47(9):1209-15. PubMed ID: 18808357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
